ReviewClinical reviews in allergy1987
Standardization of fungal allergens.
Review in Clinical reviews in allergy, 1987. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 40 citations in OpenAlex.
- Problems Encountered Using Fungal Extracts as Test Solutions for Fungal Allergy Diagnosis.Journal of fungi (Basel, Switzerland) · 2023Review
- The transaldolase, a novel allergen of Fusarium proliferatum, demonstrates IgE cross-reactivity with its human analogue.PloS one · 2014Article
- Fungal allergens.Clinical microbiology reviews · 1995Review
- The biology of allergenic domestic mites. An update.Clinical reviews in allergy & immunology · 1995Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The ability of various fungi to induce human IgE-mediated disease, especially allergic asthma, has been well established. The relative clinical importance of fungal aeroallergens varies considerably in different geographic areas. The magnitude of exposure to fungal aeroallergens can be quantitated more precisely by newer immunochemical assays than by more traditional fungal cultures or quantitation of fungal spores by microscopy. Although the wide variations in biologic potency among commercial mold allergenic extracts have been appreciated for decades, only recently have laboratory technologic advances and the production of international reference extracts permitted the development of standardized fungal extracts of defined potency. Future efforts should be directed toward documenting the expected diagnostic and therapeutic advantages of such standardized fungal extracts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.